Appellate Tribunal Upholds Valuation of Physician's Samples u/r 6(b)(ii), Emphasizes Comparability Criteria.

The Appellate Tribunal dismissed Revenue's appeal, affirming the Commissioner (Appeals)'s decision to value Physician's Samples under Rule 6(b)(ii) of the Central Excise Valuation Rules, 1975. The Tribunal emphasized the necessity for comparable goods to be identical, noting significant differences between physician's samples and wholesale products, supporting the Commissioner's approach.

---

---

Issues involved: Valuation of Physician's Samples for free distribution among Doctors through Medical Representatives.

Analysis:

1. Valuation Methodology Dispute:
- The appeal filed by Revenue challenges the OIA regarding the valuation of Physician's Samples. The Commissioner (Appeals) favored Rule 6(b)(ii) of Central Excise Valuation Rules, 1975 over Rule 6(b)(i) for valuation. The Commissioner cited differences in packing, post-manufacturing expenses, and cost value of samples as reasons for the decision.
- Revenue contested the decision, arguing that the cost construction method should be a last resort. They referred to previous decisions by CEGAT which supported valuation based on comparable price of goods as per Rule 6(b)(i).
- The learned Consultant for the Respondent highlighted that physician's samples and wholesale products differ in various aspects, and Rule 6(b)(i) should only apply when goods are used in production. He also mentioned the Supreme Court's stance on comparable goods and the Tribunal's decision regarding the valuation of smaller packs of samples.

2. Comparability of Goods:
- The Tribunal emphasized the need for comparable goods to be as identical as possible, as per the Supreme Court's ruling. They also referred to a case where the valuation of physician's samples in smaller packs was upheld using Rule 6(b)(ii) instead of pro rata increase based on commercial pack prices.
- Despite Revenue's reliance on previous CEGAT decisions, the Tribunal concluded that physician's samples and wholesale goods are not comparable, aligning with the requirement for identical goods for comparison under Rule 6(b). The Commissioner's decision was upheld based on sound reasoning and the lack of grounds for interference.

In conclusion, the Appellate Tribunal rejected Revenue's appeal, upholding the Commissioner (Appeals)'s decision to value Physician's Samples using Rule 6(b)(ii) instead of Rule 6(b)(i). The judgment emphasized the need for comparable goods to be as identical as possible and highlighted the differences between physician's samples and wholesale products. The decision was supported by the Supreme Court's stance on comparable goods and previous Tribunal rulings regarding valuation methodologies for different pack sizes.

---